Startups
Cadenza Bio is a preclinical biotechnology company focused on developing a series of novel small-molecule drugs for the treatment of demyelinating and inflammatory diseases.
Overview
Total raised
$2.44M
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Cadenza Bio | “Cadenza Bio is a preclinical biotechnology company focused on developing a series of novel small-molecule drugs for the treatment of demyelinating and inflammatory diseases.” |
Reviews 0
FAQ about Cadenza Bio
How much funding has Cadenza Bio raised?
Cadenza Bio has raised $2.44M in total across 1 funding round.
What has the press written about Cadenza Bio?
Parsers VC has collected 2 articles mentioning Cadenza Bio, among them “Cadenza Bio”.
Is Cadenza Bio still active?
Yes, Cadenza Bio is active; its latest activity on Parsers VC dates from Aug 22, 2024.